Breakthrough Cancer Drug ISB 2001 Achieves 75% Response Rate in Phase 1 Trial

Ichnos Glenmark Innovation (IGI) announced a 75% response rate for its experimental cancer drug I...

18mo ago

You're early. There are no comments yet.

Be the first to comment.

Discover more

Curated from across

50K

+jobs scanned every day

Your AI Talent Agent.
Finds you the best jobs

Ask a question on Grapevine.

Get the app on Android or iOS.